Natural Medicine Talk

Go Back   Natural Medicine Talk > Health Forums > Heart Health

LinkBack Thread Tools Display Modes
Old 01-29-2009, 09:06 PM
Harry Hirsute's Avatar
Join Date: Apr 2006
Location: Propecia, CA
Posts: 1,800
Harry Hirsute will become famous soon enough
Default NSAIDs and Cardiovascular Morbidity

Arch Intern Med. 2009 Jan 26;169(2):141-9.

Increased Mortality and Cardiovascular Morbidity Associated With Use of Nonsteroidal Anti-inflammatory Drugs in Chronic Heart Failure.

Gislason GH, Rasmussen JN, Abildstrom SZ, Schramm TK, Hansen ML, Fosbøl EL, Sørensen R, Folke F, Buch P, Gadsbøll N, Rasmussen S, Poulsen HE, Køber L, Madsen M, Torp-Pedersen C.

Department of Cardiology, Gentofte University Hospital, Niels Andersens Vej 65, 2900 Hellerup, Denmark. [email protected].

BACKGROUND: Accumulating evidence indicates increased cardiovascular risk associated with nonsteroidal anti-inflammatory drug (NSAID) use, in particular in patients with established cardiovascular disease. We studied the risk of death and hospitalization because of acute myocardial infarction and heart failure (HF) associated with use of NSAIDs in an unselected cohort of patients with HF.

METHODS: We identified 107 092 patients surviving their first hospitalization because of HF between January 1, 1995, and December 31, 2004, and their subsequent use of NSAIDs from individual-level linkage of nationwide registries of hospitalization and drug dispensing by pharmacies in Denmark. Data analysis was performed using Cox proportional hazard models adjusted for age, sex, calendar year, comorbidity, medical treatment, and severity of disease, and propensity-based risk-stratified models and case-crossover models.

RESULTS: A total of 36 354 patients (33.9%) claimed at least 1 prescription of an NSAID after discharge; 60 974 (56.9%) died, and 8970 (8.4%) and 39 984 (37.5%) were hospitalized with myocardial infarction or HF, respectively. The hazard ratio (95% confidence interval) for death was 1.70 (1.58-1.82), 1.75 (1.63-1.88), 1.31 (1.25-1.37), 2.08 (1.95-2.21), 1.22 (1.07-1.39), and 1.28 (1.21-1.35) for rofecoxib, celecoxib, ibuprofen, diclofenac, naproxen, and other NSAIDs, respectively. Furthermore, there was a dose-dependent increase in risk of death and increased risk of hospitalization because of myocardial infarction and HF. Propensity-based risk-stratified analysis and case-crossover models yielded similar results.

CONCLUSIONS: NSAIDs are frequently used in patients with HF and are associated with increased risk of death and cardiovascular morbidity. Inasmuch as even commonly used NSAIDs exerted increased risk, the balance between risk and benefit requires careful consideration when any NSAID is given to patients with HF.

PMID: 19171810 [PubMed - in process]
Increased Mortality and Cardiovascular Morbidity A...[Arch Intern Med. 2009] - PubMed Result
You're officially invited to come visit my new blog:
Reply With Quote


Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On

Similar Threads
Thread Thread Starter Forum Replies Last Post
Pomegranate and Diabetic Cardiovascular Health Harry Hirsute Diabetes 0 09-25-2008 01:47 PM
Chronic Vitamin C Deficiency Increases Cardiovascular Risk Harry Hirsute Heart Health 1 05-13-2008 02:19 PM
Air-Filtration May Protect Cardiovascular Health Harry Hirsute Heart Health 0 02-15-2008 10:56 AM
Spirulina May Benefit Cardiovascular Health Harry Hirsute Heart Health 0 02-10-2008 10:52 AM
Vitamin E May Protect the Cardiovascular System of Diabetics Harry Hirsute Diabetes 0 10-19-2007 09:05 AM

All times are GMT -8. The time now is 03:40 PM.

Powered by vBulletin® Version 3.8.1
Copyright ©2000 - 2009, Jelsoft Enterprises Ltd.
SEO by vBSEO 3.3.0 RC2 ©2009, Crawlability, Inc.